Microtubule Disruption Targets HIF-1alpha MRNA to Cytoplasmic P-bodies for Translational Repression

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 2011 Jan 12

PMID 21220510

Citations 49

Authors

Marisa Carbonaro

Aurora OBrate

Paraskevi Giannakakou

Affiliations

Soon will be listed here.

Abstract

The hypoxia inducible factor 1α (HIF-1α) is overexpressed in solid tumors, driving tumor angiogenesis and survival. However, the mechanisms regulating HIF-1α expression in solid tumors are not fully understood. In this study, we find that microtubule integrity and dynamics are intricately involved in orchestrating HIF-1α translation. HIF-1α messenger RNA (mRNA) traffics on dynamic microtubules when it is actively translated. Microtubule perturbation by taxol (TX) and other microtubule-targeting drugs stalls HIF-1α mRNA transport and releases it from polysomes, suppressing its translation. Immunoprecipitation of the P-body component Argonaute 2 (Ago2) after microtubule disruption shows significant enrichment of HIF-1α mRNAs and HIF-targeting microRNAs (miRNAs). Inhibition of HIF-repressing miRNAs or Ago2 knockdown abrogates TX's ability to suppress HIF-1α translation. Interestingly, microtubule repolymerization after nocodazole washout allows HIF-1α mRNA to reenter active translation, suggesting that microtubule dynamics exert tight yet reversible control over HIF-1α translation. Collectively, we provide evidence for a new mechanism of microtubule-dependent HIF-1α translation with important implications for cell biology.

Citing Articles

Protein aggregation and biomolecular condensation in hypoxic environments (Review).

Li C, Hao B, Yang H, Wang K, Fan L, Xiao W Int J Mol Med. 2024; 53(4).

PMID: 38362920 PMC: 10903932. DOI: 10.3892/ijmm.2024.5357.

Combinatorial regulation by ERK1/2 and CK1δ protein kinases leads to HIF-1α association with microtubules and facilitates its symmetrical distribution during mitosis.

Arseni C, Samiotaki M, Panayotou G, Simos G, Mylonis I Cell Mol Life Sci. 2024; 81(1):72.

PMID: 38300329 PMC: 10834586. DOI: 10.1007/s00018-024-05120-7.

Associations between HIFs and tumor immune checkpoints: mechanism and therapy.

Liu J, Jiang Y, Chen L, Qian Z, Zhang Y Discov Oncol. 2024; 15(1):2.

PMID: 38165484 PMC: 10761656. DOI: 10.1007/s12672-023-00836-7.

Action Sites and Clinical Application of HIF-1α Inhibitors.

Xu R, Wang F, Yang H, Wang Z Molecules. 2022; 27(11).

PMID: 35684364 PMC: 9182161. DOI: 10.3390/molecules27113426.

Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles.

Wordeman L, Vicente J Cancers (Basel). 2021; 13(22).

PMID: 34830812 PMC: 8616087. DOI: 10.3390/cancers13225650.

References

Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

Meister G, Landthaler M, Peters L, Chen P, Urlaub H, Luhrmann R . Identification of novel argonaute-associated proteins. Curr Biol. 2005; 15(23):2149-55. DOI: 10.1016/j.cub.2005.10.048. View

Schepens B, Tinton S, Bruynooghe Y, Beyaert R, Cornelis S . The polypyrimidine tract-binding protein stimulates HIF-1alpha IRES-mediated translation during hypoxia. Nucleic Acids Res. 2006; 33(21):6884-94. PMC: 1310900. DOI: 10.1093/nar/gki1000. View

Giannakakou P, Sackett D, Kang Y, Zhan Z, Buters J, Fojo T . Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem. 1997; 272(27):17118-25. DOI: 10.1074/jbc.272.27.17118. View

Gascoigne K, Taylor S . Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell. 2008; 14(2):111-22. DOI: 10.1016/j.ccr.2008.07.002. View

Giannakakou P, Sackett D, Ward Y, Webster K, Blagosklonny M, Fojo T . p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol. 2000; 2(10):709-17. DOI: 10.1038/35036335. View

Jansen R . mRNA localization: message on the move. Nat Rev Mol Cell Biol. 2001; 2(4):247-56. DOI: 10.1038/35067016. View

Brengues M, Teixeira D, Parker R . Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science. 2005; 310(5747):486-9. PMC: 1863069. DOI: 10.1126/science.1115791. View

Bratu D, Cha B, Mhlanga M, Kramer F, Tyagi S . Visualizing the distribution and transport of mRNAs in living cells. Proc Natl Acad Sci U S A. 2003; 100(23):13308-13. PMC: 263795. DOI: 10.1073/pnas.2233244100. View

10.

Guppy M, Brunner S, Buchanan M . Metabolic depression: a response of cancer cells to hypoxia?. Comp Biochem Physiol B Biochem Mol Biol. 2005; 140(2):233-9. DOI: 10.1016/j.cbpc.2004.10.005. View

11.

Tomari Y, Zamore P . Perspective: machines for RNAi. Genes Dev. 2005; 19(5):517-29. DOI: 10.1101/gad.1284105. View

12.

Ashe M, De Long S, Sachs A . Glucose depletion rapidly inhibits translation initiation in yeast. Mol Biol Cell. 2000; 11(3):833-48. PMC: 14814. DOI: 10.1091/mbc.11.3.833. View

13.

Feng Y, Absher D, Eberhart D, Brown V, Malter H, Warren S . FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol Cell. 1998; 1(1):109-18. DOI: 10.1016/s1097-2765(00)80012-x. View

14.

Andrei M, Ingelfinger D, Heintzmann R, Achsel T, Rivera-Pomar R, Luhrmann R . A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA. 2005; 11(5):717-27. PMC: 1370757. DOI: 10.1261/rna.2340405. View

15.

Aizer A, Brody Y, Ler L, Sonenberg N, Singer R, Shav-Tal Y . The dynamics of mammalian P body transport, assembly, and disassembly in vivo. Mol Biol Cell. 2008; 19(10):4154-66. PMC: 2555939. DOI: 10.1091/mbc.e08-05-0513. View

16.

Tyagi S, Kramer F . Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol. 1996; 14(3):303-8. DOI: 10.1038/nbt0396-303. View

17.

Liu J, Valencia-Sanchez M, Hannon G, Parker R . MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol. 2005; 7(7):719-23. PMC: 1855297. DOI: 10.1038/ncb1274. View

18.

Escuin D, Burke P, McMahon-Tobin G, Hembrough T, Wang Y, Alcaraz A . The hematopoietic-specific beta1-tubulin is naturally resistant to 2-methoxyestradiol and protects patients from drug-induced myelosuppression. Cell Cycle. 2009; 8(23):3914-24. DOI: 10.4161/cc.8.23.10105. View

19.

Palacios I, St Johnston D . Getting the message across: the intracellular localization of mRNAs in higher eukaryotes. Annu Rev Cell Dev Biol. 2001; 17:569-614. DOI: 10.1146/annurev.cellbio.17.1.569. View

20.

Luke B, Azzalin C, Hug N, Deplazes A, Peter M, Lingner J . Saccharomyces cerevisiae Ebs1p is a putative ortholog of human Smg7 and promotes nonsense-mediated mRNA decay. Nucleic Acids Res. 2007; 35(22):7688-97. PMC: 2190716. DOI: 10.1093/nar/gkm912. View